David R. Brennan

Biography

Mr. David R. Brennan serves as a Member of Executive Board at Pharmaceutical Research and Manufacturers of America. Mr. Brennan served as an Interim Chief Executive Officer of Alexion Pharmaceuticals, Inc. from December 12, 2016 to March 27, 2017. He served as the Chief Executive Officer of AstraZeneca Plc at MedImmune, LLC from January 1, 2006 to June 1, 2012. Mr. Brennan served as Treasurer of the Pharmaceutical Research and Manufacturers of America since March 2007. He served as the President and Chief Executive Officer of AstraZeneca Pharmaceuticals LP (which does business as Astrazeneca U.S) where he was responsible for all operations in the U.S. From 2001 to 2006, he served as President and Chief Executive Officer of AstraZeneca's North American subsidiary. Mr. Brennan served as Executive Vice President of North America Division of AstraZeneca Plc from 2001 to 2006. He served as Senior Vice President of Commercialization and Portfolio Management of AstraZeneca. Before the merger of Astra AB and Zeneca Plc, he served as Senior Vice President of Business Planning and Development of Astra Pharmaceuticals LP, the American subsidiary of Astra AB. Mr. Brennan began his career in 1975 at Merck and Co. Inc., where he rose from Sales Representative in the U.S. Division to General Manager of Chibret International, a French subsidiary of Merck that specializes in ophthalmic. He has been an Independent Chairman at Alexion Pharmaceuticals, Inc. since May 10, 2017. He served as the Chairman of Pharmaceutical Research and Manufacturers of America

Research Interest

arts & Business administration, Business planning and development Pharmacy research